A team of researchers has found a way to identify the small population of cTfh present in the blood after an annual flu vaccine to monitor their contribution to antibody strength.
Adult stem cells collected directly from human fat are more stable than other cells – such as fibroblasts from the skin – and have the potential for use in anti-aging treatments, according to recent research.
More than six decades after Castleman disease (CD) was first described, a group of experts from Penn Medicine and other institutions around the world has established the first set of diagnostic criteria for a life-threatening subtype of the condition, idiopathic multicentric CD (iMCD), which is often misdiagnosed as other illnesses.
Penn Medicine’s Orphan Disease Center (ODC) announces a new partnership with FAST (Foundation for Angelman Syndrome Therapeutics) to study gene therapy approaches to treat Angelman syndrome (AS).
Casting one of the largest genomic nets to date for the rare tumors of the autonomic nervous system known as pheochromocytoma and paraganglioma (PCC/PGL) captured several new mutations driving the disease that could serve as potential drug targets.
Researchers at Penn have discovered a significant clue which ultimately could lead new therapies for preventing heart failure following a heart attack.
Surprising new results from Penn Medicine tell a different story about the side effects experienced by patients who take the heart disease drug niacin.
Penn researchers found evidence that the cytokine Interleukin 27 (IL-27) may be the key to fighting and treating viral lung infections.
For Patients and the General Public: